Research Paper Volume 12, Issue 12 pp 11967—11989

Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis

Figure 10. The overexpression of CACYBP in patients with BCa and its correlation with grades and T-stages. The results of RT-qPCR of CACYBP expression in bladder cancer cells and normal urothelial cells (A). Western blot analysis showed that the expression of CACYBP was higher in BCa cell lines than in normal urothelial cells (B). Increasing expression levels of CACYBP were detected by immunohistochemistry (C). CACYBP was also increased in various grades incrementally (D).